FREE WEBINAR: Health New Zealand presents Te Tiri Whakāro: Sharing Knowledge, a webinar series to support primary care. This webinar will cover two clinical sessions focused on evolving international approaches to cardiovascular risk management, alongside the standing segment of clinical updates.
Blood pressure management: What’s changing?
Lia Shanks will discuss evolving approaches to blood pressure management, including recent international evidence and changing treatment targets. The session will consider what these developments may mean, with a practical focus on supporting cardiovascular risk reduction.
LDL cholesterol: New targets and how to get there
Linda Bryant will explore the changing approach to LDL cholesterol management, including the evidence behind lower LDL cholesterol targets and what this means in practice. She will provide practical suggestions to help patients achieve these targets and reduce cardiovascular risk.
General updates
with Sue Tutty.
As always, we will answer as many questions as possible.
Presenter
Lia Shanks
Lia is a Nurse Practitioner at Te Pae Hauora O Ruahine o Tararua|MidCentral; Lia is also a co-lead for the National Cardiac Clinical Network for Te Whatu Ora|Health New Zealand.
Lia’s particular areas of interest are the management of advanced heart failure, advanced care planning, and improving the accessibility and availability of specialist nursing services for those who are disadvantaged.
Lia provides integrated health care delivery by working across primary, secondary and palliative services to educate and support patients, their whānau, and health professionals to manage the complexity of cardiac and associated conditions.
Presenter
Linda Bryant
MClin Pharm, PhD, PGcert (prescribing)
Linda is a pharmacist prescriber working at Newtown Union Health.
She is an Honorary Academic in the Department of General Practice and Primary Health Care at the University of Auckland and has over twenty years’ experience teaching postgraduate clinical pharmacy. Her interest is focusing on reducing drug-related morbidity and mortality and addressing inequities through individualising medicines therapy.
Supported by
